3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Carcinoma, Non-Small-Cell Lung
12
Recurrence
8
Lung Neoplasms
6
Neoplasm Metastasis
5
Lymphoma, T-Cell, Peripheral
4
Breast Neoplasms
4
Neoplasms
3
Lymphoma, T-Cell
3
Urinary Bladder Neoplasms
2
Stomatitis
2
Sezary Syndrome
2
Papillomavirus Infections
2
Nasopharyngeal Carcinoma
2
Mycosis Fungoides
2
Meningeal Carcinomatosis
2
Lymphoma, T-Cell, Cutaneous
2
Lymphoma, B-Cell
2
Lymphoma
2
Head and Neck Neoplasms
2
Carcinoma, Transitional Cell
2
Anemia
2
Waldenstrom Macroglobulinemia
1
Vitamin B 12 Deficiency
1
Ureteral Neoplasms
1
Thyroid Diseases
1
Thrombocytopenia
1
Stroke
1
Stomach Neoplasms
1
Smoking
1
Prostatic Neoplasms
1
Interventions
Acupuncture Therapy
10
Exercise
7
Cryotherapy
6
Paclitaxel
5
Glutamine
5
Surveys and Questionnaires
3
Duloxetine Hydrochloride
3
Dexamethasone
3
Bortezomib
3
Acetylcysteine
3
pembrolizumab
2
enfortumab vedotin
2
Thioctic Acid
2
Tablets
2
Sodium Chloride
2
Saline Solution
2
Physical Therapy Modalities
2
Low-Level Light Therapy
2
Fish Oils
2
Fatty Acids, Omega-3
2
ziconotide
1
sagopilone
1
nicotinamide-beta-riboside
1
nabilone
1
glutamic acid diethyl ester
1
allantoicase
1
Yoga
1
XELOX
1
Vitamin D
1
Vitamin B Complex
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Peripheral Nervous System Diseases
×
Vitamin B 12
×
Clear all
NCT02795572
2019-07-05
CIPN
AHS Cancer Control Alberta
Phase 2
Terminated
13 enrolled